Translating Novel & Transformational Analgesics into the Clinic

Transforming Efficacy & Tolerability of Pain Management with Nav 1.8 & Other Targets for Neuropathic, Chemotherapy-Induced, Musculoskeletal & Other Types of Pain

For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to market.

Whether advancing NaV-targeting drugs or pursuing novel pain mechanisms, non-opioid therapeutics are now in the clinical spotlight and the next 12 months promise to be transformative.

The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness that momentum. Attendees will be learning from companies with approvals such as Tonix, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join 70+ discovery, preclinical, translational and clinical industry-based experts driving the future of non-opioid pain therapies across diverse pain indications.

Nice blend of emerging science, translational medicine and clinical development. Conference was not overwhelmingly large which allowed for great networking.

Abbvie

(World CNS Series)

AbbVie_logo - Non-Opioid Pain Therapeutics Summit

The pre-conference workshop and presentations were of great quality, and the audience was interactive throughout. The small group roundtables fostered meaningful discussions

Merck

(World CNS Series)

merck logo - Non-Opioid Pain Therapeutics Summit

Opportunities for networking with various companies and experts in the space, informing both successes and challenges as well as brainstorm on the most likely productive path forward

Medicenna Therapeutic

(World CNS Series)

medicenna-therapeutics- Non-Opioid Pain Therapeutics Summit

Explore the Full Event Guide

  • 16+ world class speakers
  • 3 days of packed content from industry experts
  • 2 interactive workshops with practical insights
  • Your dedicated forum to the pharmaceutical development of non-opioid pain therapeutics
Brochure Image - Non-Opioid Pain Therapeutics Summit

More than a Meeting

70+

Industry Dedicated Attendees

16

World-Class Speakers

5+

Hours of Dedicated Networking

3

Days of Packed Content From Industry Experts

2

Interactive Workshops With Practical Insights

Attending Companies Include

AbbVie_logo - Non-Opioid Pain Therapeutics Summit
Tonix Pharmaceuticals - Non-Opioid Pain Therapeutics Summit
novartis logo - Non-Opioid Pain Therapeutics Summit
Eli Lilly logo - Non-Opioid Pain Therapeutics Summit
orion - Non-Opioid Pain Therapeutics Summit
algiax pharmaceuticals - Non-Opioid Pain Therapeutics Summit
Latigo - Non-Opioid Pain Therapeutics Summit
onsite image 2
Explore the Agenda

Interactive workshops, pharma panels and case-study led presentations: hear the industries exclusive insights

onsite image 3
Partner With Us

Position yourself alongside pioneering biopharma to centre your solutions at the heart of a booming industry

onsite image 4
Join Pain Experts

Be part of critical conversations with expert- attendees during dedicated networking hours